866-997-4948(US-Canada Toll Free)

Age-related macular degeneration (AMD)- Market Insights, Epidemiology and Market Forecast-2023

Published By :

DelveInsight

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 100 Pages

DelveInsights Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Age-related macular degeneration (AMD) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Age-related macular degeneration (AMD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Age-related macular degeneration (AMD) till 2023.

Key Coverage and Benefits

The report will help in developing business strategies by understanding the trends shaping and driving the global Age-related macular degeneration (AMD) market.
Identifying patient populations in the global Age-related macular degeneration (AMD) market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Age-related macular degeneration (AMD) therapeutics in each of the markets covered.
To understand the future market competition in the global Age-related macular degeneration (AMD) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023.
The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
It also provides Age-related macular degeneration (AMD) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Note: This report requires 5-7 business days to complete.

 


Age-related macular degeneration (AMD) overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Age-related macular degeneration (AMD) Market
Global Epidemiology of Age-related macular degeneration (AMD) Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight

List of Tables

Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Age-related macular degeneration (AMD) Drug Sales (USD Millions)
Table 6: Global Epidemiology of Age-related macular degeneration (AMD) (2013-2023)
Table 7: Age-related macular degeneration (AMD) Global Market (USD Millions), (2013-2015)
Table 8: Age-related macular degeneration (AMD) Global Market (USD Millions), (2016-2023)
Table 9: Age-related macular degeneration (AMD) US Market (USD Millions), (2013-2015)
Table 10: Age-related macular degeneration (AMD) US Market (USD Millions), (2016-2023)
Table 11: Age-related macular degeneration (AMD) Germany Market (USD Millions), (2013-2015)
Table 12: Age-related macular degeneration (AMD) Germany Market (USD Millions), (2016-2023)
Table 13: Age-related macular degeneration (AMD) United Kingdom Market (USD Millions), (2013-2015)
Table 14: Age-related macular degeneration (AMD) United Kingdom Market (USD Millions), (2016-2023)
Table 15: Age-related macular degeneration (AMD) France Market (USD Millions), (2013-2015)
Table 16: Age-related macular degeneration (AMD) France Market (USD Millions), (2016-2023)
Table 17: Age-related macular degeneration (AMD) Italy Market (USD Millions), (2013-2015)
Table 18: Age-related macular degeneration (AMD) Italy Market (USD Millions), (2016-2023)
Table 19: Age-related macular degeneration (AMD) Spain Market (USD Millions), (2013-2015)
Table 20: Age-related macular degeneration (AMD) Spain Market (USD Millions), (2016-2023)
Table 21: Age-related macular degeneration (AMD) Japan Market (USD Millions), (2013-2015)
Table 22: Age-related macular degeneration (AMD) Japan Market (USD Millions), (2016-2023)
Table 23: Age-related macular degeneration (AMD) ROW Market (USD Millions), (2013-2015)
Table 24: Age-related macular degeneration (AMD) ROW Market (USD Millions), (2016-2023)


List of Figures

Figure 1: Age-related macular degeneration (AMD) Drug Sales (USD Millions)
Figure 2: Global Epidemiology of Age-related macular degeneration (AMD) (2013-2023)
Figure 3: Age-related macular degeneration (AMD) Global Market (USD Millions), (2013-2015)
Figure 4: Age-related macular degeneration (AMD) Global Market (USD Millions), (2016-2023)
Figure 5: Age-related macular degeneration (AMD) US Market (USD Millions), (2013-2015)
Figure 6: Age-related macular degeneration (AMD) US Market (USD Millions), (2016-2023)
Figure 7: Age-related macular degeneration (AMD) Germany Market (USD Millions), (2013-2015)
Figure 8: Age-related macular degeneration (AMD) Germany Market (USD Millions), (2016-2023)
Figure 9: Age-related macular degeneration (AMD) United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Age-related macular degeneration (AMD) United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Age-related macular degeneration (AMD) France Market (USD Millions), (2013-2015)
Figure 12: Age-related macular degeneration (AMD) France Market (USD Millions), (2016-2023)
Figure 13: Age-related macular degeneration (AMD) Italy Market (USD Millions), (2013-2015)
Figure 14: Age-related macular degeneration (AMD) Italy Market (USD Millions), (2016-2023)
Figure 15: Age-related macular degeneration (AMD) Spain Market (USD Millions), (2013-2015)
Figure 16: Age-related macular degeneration (AMD) Spain Market (USD Millions), (2016-2023)
Figure 17: Age-related macular degeneration (AMD) Japan Market (USD Millions), (2013-2015)
Figure 18: Age-related macular degeneration (AMD) Japan Market (USD Millions), (2015-2023)
Figure 19: Age-related macular degeneration (AMD) ROW Market (USD Millions), (2013-2015)
Figure 20: Age-related macular degeneration (AMD) ROW Market (USD Millions), (2016-2023)

 

List of Table

Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Age Drug Sales (USD Millions)
Table 6: Global Epidemiology of Age(2013-2023)
Table 7: Age Global Market (USD Millions), (2013-2015)
Table 8: Age Global Market (USD Millions), (2016-2023)
Table 9: Age US Market (USD Millions), (2013-2015)
Table 10: Age US Market (USD Millions), (2016-2023)
Table 11: Age Germany Market (USD Millions), (2013-2015)
Table 12: Age Germany Market (USD Millions), (2016-2023)
Table 13: Age United Kingdom Market (USD Millions), (2013-2015)
Table 14: Age United Kingdom Market (USD Millions), (2016-2023)
Table 15: Age France Market (USD Millions), (2013-2015)
Table 16: Age France Market (USD Millions), (2016-2023)
Table 17: Age Italy Market (USD Millions), (2013-2015)
Table 18: Age Italy Market (USD Millions), (2016-2023)
Table 19: Age Spain Market (USD Millions), (2013-2015)
Table 20: Age Spain Market (USD Millions), (2016-2023)
Table 21: Age Japan Market (USD Millions), (2013-2015)
Table 22: Age Japan Market (USD Millions), (2016-2023)
Table 23: Age ROW Market (USD Millions), (2013-2015)
Table 24: Age ROW Market (USD Millions), (2016-2023)

List of Chart

Figure 1: Age Drug Sales (USD Millions)
Figure 2: Global Epidemiology of Age(2013-2023)
Figure 3: Age Global Market (USD Millions), (2013-2015)
Figure 4: Age Global Market (USD Millions), (2016-2023)
Figure 5: Age US Market (USD Millions), (2013-2015)
Figure 6: Age US Market (USD Millions), (2016-2023)
Figure 7: Age Germany Market (USD Millions), (2013-2015)
Figure 8: Age Germany Market (USD Millions), (2016-2023)
Figure 9: Age United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Age United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Age France Market (USD Millions), (2013-2015)
Figure 12: Age France Market (USD Millions), (2016-2023)
Figure 13: Age Italy Market (USD Millions), (2013-2015)
Figure 14: Age Italy Market (USD Millions), (2016-2023)
Figure 15: Age Spain Market (USD Millions), (2013-2015)
Figure 16: Age Spain Market (USD Millions), (2016-2023)
Figure 17: Age Japan Market (USD Millions), (2013-2015)
Figure 18: Age Japan Market (USD Millions), (2015-2023)
Figure 19: Age ROW Market (USD Millions), (2013-2015)
Figure 20: Age ROW Market (USD Millions), (2016-2023)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *